FDA has now approved KEYTRUDA (pembrolizumab) for a second indication based on a tumor biomarker rather than the originating source of the tumor in the body.  Specifically, FDA has approved KEYTRUDA for patients with an unresectable or metastatic solid tumor with a high mutational burden (i.e, 10 or more mutations).  As part of this approval, FDA has also approved Foundation...

We hope you will join us this Father's Day Weekend (June 20th and 21st) for our 14th Annual Appendix Cancer/PMP VIRTUAL Walk/Run! This is our first 100% VIRTUAL walk/run and that means you can participate from ANYWHERE IN THE WORLD! Register to walk, run, hike, bike -- whatever you choose, or make a donation and be entered into the raffle for an...

Beck Schroeder's 8th birthday party looked very similar to how most other kids ring in another year -- Balloons, cake, decorations, and friends. But one thing was noticeably missing, there weren't any birthday gifts in sight. When Beck's 8th birthday was around the corner, he decided to do something different. Beck, from Prior Lake, Minnesota, asked that his friends make...

Unfortunately, rare cancer does not halt in the face of COVID-19. Many of our patients continue to need treatment, surgeries and scans in the wake of this pandemic. Many of our patients are immunocompromised. Fighting a rare disease with no cure is a constant uphill battle. We hope to keep up our momentum towards finding a cure by funding promising...

Join the Society of Surgical Oncology (SSO) on Monday, May 4, at 5 PM CDT or 6 PM EST for a virtual tumor board to discuss the current state of surgery for peritoneal surface disease. Click here to register and join: http://SSO.informz.net/z/cjUucD9taT03OTE0NTY0JnA9MSZ1PTc4OTM4MjI2NSZsaT02NTMxOTUzMA/index.html  Panelists from across the country will provide an update on the current state of COVID-19 and cover current practices in the...

The ACPMP Research Foundation is excited to share that we are now a research partner of the Wake Forest Organoid Research Center (WFORCE). WFORCE is a joint effort between the Wake Forest Institute for Regenerative Medicine and the Wake Forest Comprehensive Cancer Center and brings together researchers and clinicians, working side by side, to leverage the use of tissue organoid technology for the benefit of...

April 19th-25th National Volunteer Week is an opportunity to recognize and thank volunteers who lend their time, talents, voice and support to the ACPMP Research Foundation. Our volunteers are all incredible individuals that make a difference in many capacities and are critical to the success of our organization, we could not thank you all enough! We hope to shine a light...

The ACPMP Research Foundation shared an overview of recommendations and resources for appendix cancer and PMP patients regarding COVID-19 on March 13, 2020. ACPMP is here to help you navigate through this difficult time and we will continue to bring you the most relevant information regarding COVID-19 and cancer. Please also continue to follow the suggestions on prevention and care expressed by...

Susan Ortega began volunteering with the ACPMP Research Foundation 10 years ago this Spring. Susan currently serves on ACPMP’s Board of Directors as Secretary and is also the IT Director with our volunteer staff. Susan was diagnosed with appendix cancer in 2009. Following a successful CRS/HIPEC surgery, six months later she wanted to get involved with ACPMP. She wanted to...

Check out our other posts: COVID-19 vaccine considerations for appendix cancer and pseudomyxoma peritonei patients Updated resources for appendix cancer and pseudomyxoma peritonei patients regarding COVID-19   What is COVID-19? There are many types of coronaviruses, which can cause different types of viral infections. The type of coronavirus in the news right now is the 2019 Novel Coronavirus (SARS-CoV-2 is...